We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

234 hedge funds and large institutions have $3.41B invested in Jazz Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 234 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

57% less call options, than puts

Call options by funds: $26.3M | Put options by funds: $60.9M

Holders
234
Holders Change
+234
Holders Change %
–
% of All Funds
7.64%
Holding in Top 10
10
Holding in Top 10 Change
+10
Holding in Top 10 Change %
% of All Funds
0.33%
New
234
Increased
–
Reduced
–
Closed
–
Calls
$26.3M
Puts
$60.9M
Net Calls
-$34.6M
Net Calls Change
-$34.6M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
76
UBS AM
Illinois
$6.12M +$5.45M +89,098 New
Goldman Sachs
77
Goldman Sachs
New York
$5.8M +$5.16M +84,406 New
PP
78
Paloma Partners
Connecticut
$5.68M +$5.05M +82,692 New
Ohio Public Employees Retirement System (OPERS)
79
Ohio Public Employees Retirement System (OPERS)
Ohio
$5.46M +$4.86M +79,446 New
EMFAT
80
Emerald Mutual Fund Advisers Trust
Pennsylvania
$5.42M +$4.82M +78,930 New
AII
81
AGF Investments Inc
Ontario, Canada
$5.32M +$4.73M +77,397 New
Charles Schwab
82
Charles Schwab
California
$5.14M +$4.5M +73,669 New
State Board of Administration of Florida Retirement System
83
State Board of Administration of Florida Retirement System
Florida
$5.02M +$4.47M +73,092 New
Millennium Management
84
Millennium Management
New York
$5.02M +$4.46M +73,020 New
O
85
OrbiMed
New York
$4.95M +$4.4M +72,000 New
HR
86
Howe & Rusling
New York
$4.81M +$4.28M +69,995 New
QBFM
87
QS Batterymarch Financial Management
New York
$4.62M +$4.11M +67,200 New
ICRM
88
Insight Capital Research & Management
California
$4.5M +$4M +65,496 New
FSA
89
Franklin Street Advisors
North Carolina
$4.49M +$4M +65,385 New
SGAM
90
Smith Group Asset Management
Texas
$4.33M +$3.85M +63,052 New
NTCOC
91
Northern Trust Company of Connecticut
Connecticut
$4.08M +$3.63M +59,358 New
PCP
92
Perimeter Capital Partners
Georgia
$4.04M +$3.59M +58,730 New
RhumbLine Advisers
93
RhumbLine Advisers
Massachusetts
$3.65M +$3.25M +53,110 New
SB
94
Suntrust Banks
Georgia
$3.55M +$3.16M +51,652 New
LOAMU
95
Lombard Odier Asset Management (USA)
New York
$3.44M +$3.06M +50,000 New
KCM
96
Kingdon Capital Management
New York
$3.4M +$3.02M +49,439 New
EWM
97
Evercore Wealth Management
New York
$3.38M +$3.01M +49,200 New
PAM
98
Panagora Asset Management
Massachusetts
$3.13M +$2.78M +45,522 New
TAM
99
Tealwood Asset Management
Minnesota
$3.1M +$2.75M +45,065 New
Swiss National Bank
100
Swiss National Bank
Switzerland
$3.07M +$2.73M +44,700 New
2 3
4
5 6

JAZZ Hedge Fund Activity: Q2 2013 in Review

234 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q2 2013, worth a combined $3.41B.

Buyers outnumbered sellers: 234 funds opened new JAZZ positions and 0 closed out — a net gain of 234 holders — while 0 added to existing stakes and 0 trimmed.

  • 234 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $3.41B of Jazz Pharmaceuticals stock for Q2 2013.
  • 234 funds opened new Jazz Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +234 holders.

Based on aggregated 13F filings for Q2 2013.